Amgen

IMLYGIC

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / IMLYGIC – J9325

Manufacturer:

Amgen

Name:

IMLYGIC

HCPCS Code Descriptor:

Injection, talimogene laherparepvec, per 1 million plaque forming units

Category:

J Code

HCPCS:

J9325

NDC(s):

55513-0078-01, 55513-0079-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Injection

About:

IMLYGIC is an Oncology drug manufactured by Amgen and administered via the Injection route of administration. The J Code: J9325 is aligned to the drug IMLYGIC.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/17

HCPCS Effective Date:

1/1/17

HCPCS Short Description:

Inj talimogene laherparepvec

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.amgenassist.com/copay

http://www.amgensafetynetfoundation.com